Jordi Galván

8PUBLICATIONS
27CO-AUTHORS
Pharmaceutical delivery technologiesCancer therapy (excl. chemotherapy and radiation therapy)Pacific Peoples medicine and treatmentsMajor global burdens of disease
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Aug 10, 2026
Adherence to CAL/BDP PAD-Cream Influences Treatment Effectiveness and Preference in Scalp Psoriasis Under Real-Life Conditions: Results from the Prospective, Multicenter, Observational PRO-SCALP Study.

|Jul 01, 2026
Early Response to Calcipotriol and Betamethasone Dipropionate PAD-Cream at Week 4 in Patients with Mild-to-Moderate Plaque Psoriasis: A Post-Hoc Pooled Analysis of Two Phase III Trials.

|Jul 31, 2025
Retrospective study of onychomycosis patients treated with ciclopirox 8% HPCH and oral antifungals applying artificial intelligence to electronic health records.

Gastón Roustan, José Luis López Estébaranz, Pablo De La Cueva

|May 26, 2024
Real-world use, perception, satisfaction, and adherence of calcipotriol and betamethasone dipropionate PAD-cream in patients with plaque psoriasis in Spain and Germany: results from a cross-sectional, online survey.

José Luis López Estebaranz, Hjalmar Kurzen, Jordi Galván

|Mar 08, 2024
Burden of Topical Treatments in Psoriasis and Preferred Criteria of Choice: A Survey-Based Evaluation of Patients in Europe.

Anthony Bewley, Lauren Hiribarne, Jordi Galván

|Sep 23, 2023
Calcipotriol and Betamethasone Dipropionate Cream Based on PAD Technology for the Treatment of Plaque Psoriasis: A Narrative Review.

Tiago Torres, Jordi Galván, Nigel Crutchley

Pageof 2

Frequent Collaborators

4 joint publications

Anthony Bewley

3 joint publications

Andreas Pinter

3 joint publications

José Luis López Estebaranz

2 joint publications

Morten Praestegaard